Youth, Advocates: Mife is safe, no matter where it’s taken.

This weekend, a federal appeals court in Louisiana reinstated a requirement forcing patients to access mifepristone in-person at health care facilities. By limiting telehealth access to one of two FDA-approved medications proven to safely end a pregnancy, the decision paves the way for higher barriers to abortion nationwide. The Supreme Court has stayed the decision until May 11th. 

In response, Tamara Marzouk, Director of Abortion Access at Advocates for Youth, issued the following statement:

“Once again, anti-abortion judges have ignored decades of research and allowed politics and extremism to shape decisions about life-saving health care. Mifepristone is safe and effective – whether taken in a brick-and-mortar clinic or at home, via telehealth. 

Making patients jump through hoops to access care helps no one and could force many more patients to continue unwanted pregnancies. Restrictions on abortion care take the highest toll on young people, and particularly on young people who rely on telehealth due to privacy concerns and barriers to travel. 

We must work toward a future where every young person can make decisions about their body and their future unobstructed by political extremism or judicial activism. We urge the Supreme Court to honor decades of scientific and medical research and take action to preserve access to mifepristone through telehealth.”

Experts and advocates are available for interviews to discuss how restrictions on telehealth will impact young people seeking abortions.

###

Advocates for Youth is a 501(c)3 organization that champions efforts that help young people make informed decisions about their reproductive and sexual health. Advocates for Youth boldly advocates for a more positive and realistic approach to adolescent sexual health, focusing its work on young people ages 14-24 in the U.S. and around the globe. 

For Immediate Release: May 4, 2026

Contact: Eleanor Naiman, [email protected]